Clinical trial
Safety and Efficacy of Single Agent Obatoclax Mesylate (GX15-070MS) Followed by…
NCT00427856 · Gemin X, Industry · Completed
Key facts
| NCT number | NCT00427856 |
|---|---|
| Title | Safety and Efficacy of Single Agent Obatoclax Mesylate (GX15-070MS) Followed by a Combination With Rituximab for Previously-untreated Follicular Lymphoma (FL) |
| Official title | A Multi-Center, Open-Label, Phase II Study of Sequential, Single-Agent Obatoclax Mesylate (GX15-070MS)Followed by a Combination With Rituximab to Patients With Previously-Untreated Follicular Lymphoma (FL) |
| Lead sponsor | Gemin X, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma, Follicular |
| Intervention type | Drug |
| Interventions | Obatoclax mesylate, Rituximab |
| Enrollment | 7 |
| Start date | Mar 1, 2007 |
| Primary completion | Feb 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Jan 29, 2007 |
| Last update posted | Jul 22, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: